Skip to content
  • English
  • Business
  • Entertainment
  • National
  • Lifestyle
  • Education
Daily News India

Daily News India

Just another WordPress site

  • English
  • Business
  • Entertainment
  • National
  • Lifestyle
  • Education
  • Toggle search form
  • Cube Federation of India and Mindgamez Announce MIST 2025 Monsoon SpeedCubing Tournament Business
  • Expert trainer Sandesh Deshmukh has made it his life’s work to enhance human health and happiness Business
  • Nick Cassidy Wins USA Formula E Race As Jake Dennis Takes Championship Lead – Round 12 – 2023 Southwire Portland E-PRIX Press Release
  • Maagh Advertising, The Leading Name of The Industry Is Bringing an IPO on 26 September Business
  • Award-Winning, Burmese Restaurant & Tea Room – Burma Burma opens at Palladium, Ahmedabad Lifestyle
  • Jaipur realtor Mohit Jajoo honoured with AsiaOne Most Influential Young Leader 2021-22 award in New Delhi Business
  • After Her powerful debut in ‘Bad Boy,’ Amrin Has Been Signed By 4 Big Production Houses From South Industry Press Release
  • Dr. Sanjay N, A Platinum Elite Invisalign Provider, Helps Patients Tackle Dental Issues With Invisible Braces Health

Hetero Healthcare and Enzene Launch Perzea: Affordable Pertuzumab Biosimilar Expands Breast Cancer Treatment Access in India

Posted on September 25, 2025 By

Hyderabad (Telangana) [India], September 25: In a landmark initiative to expand affordable breast cancer treatment in India, Hetero Healthcare Limited has announced the launch of Perzea, its most cost-effective biosimilar of Pertuzumab. Developed through a semi-exclusive collaboration with Enzene Biosciences Limited, this breakthrough aims to reduce the economic barriers faced by thousands of HER2-positive breast cancer patients.

Bringing Advanced Cancer Care Within Reach
Pertuzumab, a monoclonal antibody, is globally recognised as a HER2-positive breast cancer therapy when administered with trastuzumab and chemotherapy. Despite its proven efficacy, the high cost of treatment has restricted access in India. With Perzea, Hetero Healthcare is determined to change this reality, offering patients a therapy that balances global standards of care with local affordability.

Mr. M. Srinivas Reddy, Managing Director of Hetero Healthcare Limited, commented:
“Our focus has always been to make advanced therapies more accessible without compromising on quality. With Perzea, we take a decisive step towards ensuring that no patient is denied life-saving care due to affordability challenges.”

Commitment to Patient-Centred Healthcare
Aligned with the Government of India’s mission of equitable healthcare, Perzea strengthens Hetero Healthcare’s legacy of delivering low-cost oncology medicines across critical therapeutic areas. For breast cancer patients and their families, this launch provides renewed hope by combining affordability with innovation.

About Hetero Healthcare
Hetero Healthcare Limited is among India’s leading pharmaceutical companies, delivering high-quality medicines across oncology, antiretrovirals, and critical care. The company’s focus on patient-centric innovation continues to drive better outcomes across India. Learn more: www.heterohealthcare.com

About Enzene Biosciences
Enzene is a fully integrated biologics innovator with its patented EnzeneX™ continuous manufacturing technology. Operating from Pune (India) and New Jersey (USA), Enzene is transforming biologics production efficiency and affordability. Learn more: www.enzene.com

Disclaimer: This article is for general information purposes only and should not be construed as professional medical advice. Always consult your doctor before taking any step.

Health Tags:Health

Post navigation

Previous Post: Meeta Vihang Kotadia Wins 2nd Runner-Up Title as Mrs. India International World
Next Post: Anjum J Parveen: A Journey of Self-Discovery, Healing, and Hope Through Words

Related Posts

  • When Science Meets Soul: Dr. Tarang Krishna’s Integrative Approach to Beating Cancer Health
  • HART Ring by FITTR: Transforming Health Monitoring Across India Health
  • JIPSI and Dr. Gaurav Kant Sharma: Revolutionizing Sports Injury Treatment for Athletes Health
  • Dr Sushil Mehtaa’s speciality Consultation starts at Charni Road Mumbai Health
  • Dr Megha Nagpal a celebrity facial aesthetician par excellence Health
  • Meitra Hospital Announces Launch of Robotic Joint Replacement Surgery Health

Recent Posts

  • Nikka Zaildar 4: Romance, Delays & Flood Relief — Punjabi Saga Returns With Heart and Hurdles
  • Prime Minister Narendra Modi Vijaya Dashami Greetings: 2025
  • Investing in an IPO: 7 Critical Strategies for Amazing Returns
  • Elixir Wellness Named Healthcare Startup of the Year at Entrepreneur India 2025
  • Shah Rukh Khan Becomes Bollywood’s First Billionaire | The Rise of the Billionaire Badshah

Recent Comments

  • Unknown on Participants Reap Rewards in Wellman’s 8-Week Digital Campaign: IPL Tickets, Autographed Virat Kohli Merchandise, and More!
  • Anand Chouhan Is Creating Waves In Marketing Domain With His Unique Digital Marketing Skills Business
  • Presto Revolutionizes Testing and Measurement In 2023 With State-of-the-art Testing Equipment Business
  • Vincitore Group founder Saubhagyaa R Swain soon to hit the Bloomberg billionaire Index Business
  • PAFI’s 9th National Forum is based on the theme India@100—Scale, Speed, and Sustainability Press Release
  • Art Life Gallery Hosts Inaugural Exhibition by 11-Year-Old Prodigy Rudransh Saxena Lifestyle
  • India Expo Centre & Mart Bags “National Tourism Award 2018-19 For Best Standalone Convention Centre” Business
  • A new Feat – another 100,000 graduates from Zion Christian Mission Center Press Release
  • SOLANKI Group Director Mrs. Rekha Solanki Signs MoU Worth 100 Crores with Gujarat Government for Textile Weaving and Polyester Yarn Manufacturing Plant with Advanced Technologies Business

Copyright © 2025 Daily News India.

Powered by PressBook News WordPress theme